Literature DB >> 26125994

Ophthalmic and Glaucoma Treatment Characteristics Associated With Changes in Health-related Quality of Life Before and After Newly Diagnosed Primary Open-angle Glaucoma in Nurses' Health Study Participants.

Lucy A Bailey1, Olivia I Okereke, Ichiro Kawachi, George A Cioffi, Louis R Pasquale, Jae H Kang.   

Abstract

PURPOSE: To identify attributes related to glaucoma diagnosis or early glaucoma treatment patterns that are associated with changes in health-related quality of life among those with newly diagnosed primary open-angle glaucoma.
METHODS: Among Nurses' Health Study participants with incident medical record-confirmed primary open-angle glaucoma diagnosed in 1992 to 2000, we included 317 women who completed the Short Form-36 Health Survey prediagnosis and postdiagnosis. The 2 primary outcomes were 4-year changes (1992 to 1996 or 1996 to 2000) in the physical and mental component summary scores. Multiple regression models were used to estimate differences in score changes by early treatment pattern history and characteristics as of diagnosis (ie, number of eyes affected, history of cataract, macular degeneration, cup-to-disc ratio, intraocular pressure, visual field loss type).
RESULTS: In multivariable models, no ophthalmologic characteristics were associated with physical component score change. However, compared with treatment with eye drops or pills only, laser trabeculoplasty treatment (concomitant with history of treatment with eye drops or pills in 84%) was associated with a worse mental component score change over 4 years (-2.5 units; 95% confidence interval: -4.6, -0.3); this association was stronger with a family history of glaucoma (P-interaction=0.04) or with bilateral disease (P-interaction=0.001).
CONCLUSIONS: Among patients with incident glaucoma, no major factors were associated with change in physical well being. However, compared with medical treatment only, a history of laser trabeculoplasty, which was commonly accompanied with a history of medical treatment and likely represented the need for a second line of treatment, was associated with a worse decline in mental well being.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26125994      PMCID: PMC4690806          DOI: 10.1097/IJG.0000000000000304

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  27 in total

1.  Preventing depression in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby; William S Tasman
Journal:  Arch Gen Psychiatry       Date:  2007-08

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Impact of severity and bilaterality of visual impairment on health-related quality of life.

Authors:  Rohit Varma; Joanne Wu; Kelly Chong; Stanley P Azen; Ron D Hays
Journal:  Ophthalmology       Date:  2006-08-04       Impact factor: 12.079

Review 4.  An assessment of the health and economic burdens of glaucoma.

Authors:  Rohit Varma; Paul P Lee; Ivan Goldberg; Sameer Kotak
Journal:  Am J Ophthalmol       Date:  2011-10       Impact factor: 5.258

5.  Fear of falling and visual field loss from glaucoma.

Authors:  Pradeep Y Ramulu; Suzanne W van Landingham; Robert W Massof; Emilie S Chan; Luigi Ferrucci; David S Friedman
Journal:  Ophthalmology       Date:  2012-04-04       Impact factor: 12.079

6.  Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma.

Authors:  Renato Lisboa; Yeoun Sook Chun; Linda M Zangwill; Robert N Weinreb; Peter N Rosen; Jeffrey M Liebmann; Christopher A Girkin; Felipe A Medeiros
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

7.  Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time.

Authors:  Nancy K Janz; Patricia A Wren; Kenneth E Guire; David C Musch; Brenda W Gillespie; Paul R Lichter
Journal:  Ophthalmology       Date:  2007-05-09       Impact factor: 12.079

8.  Argon Laser Trabeculoplasty in Glaucoma: What's Happening (Survey Results of American Glaucoma Society Members).

Authors:  A L Schwartz
Journal:  J Glaucoma       Date:  1993       Impact factor: 2.503

9.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Severity of visual field loss and health-related quality of life.

Authors:  Roberta McKean-Cowdin; Rohit Varma; Joanne Wu; Ron D Hays; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2007-04-02       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.